NCT03690492

Brief Summary

The objective of this study is to determine the effect on quality of care when introducing smart technology in patients who underwent cardiovascular surgery. Patients who consent to take part in the study, receive a box containing two smartphone compatible ECG monitors, an oxygen saturation monitor, a weight scale, a thermometer, an activity tracker and a blood pressure monitor. They will be followed up by replacing one of the outpatient clinic visits by an e-consult, in which a patients does not have to go to the hospital. Instead, he or she will talk with his or her doctor or nurse practitioner via a secured video connection. The primary endpoint of the study will be the diagnosis of atrial fibrillation within 3 months after cardiac surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
730

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 1, 2018

Completed
1 day until next milestone

Study Start

First participant enrolled

October 2, 2018

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2021

Completed
Last Updated

September 8, 2021

Status Verified

September 1, 2021

Enrollment Period

2.5 years

First QC Date

September 24, 2018

Last Update Submit

September 7, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Dectection of and time to detection of atrial fibrillation

    Diagnosis of atrial fibrillation and the time it took a subject to reach that outcome, measured in both study arms

    Until 3 months after surgery

Secondary Outcomes (10)

  • Dectection of and time to detection of cardiac decompensation

    Until 3 months after surgery

  • Quality of Life (QoL)

    3 months after surgery

  • Patient satisfaction of care

    3 months after surgery

  • Overall mortality

    3 months after surgery

  • Major adverse cardiac events

    Until 3 months after surgery

  • +5 more secondary outcomes

Study Arms (2)

The Box 2.0

EXPERIMENTAL

Patients will be given a Box, in which they will find a thermometer, blood pressure monitor, activity tracker, weight scale, blood oxygen saturation monitor, a single lead ECG device and a four lead ECG device. Also, they will be followed-up by use of two webcam consultations instead of a normal outpatient clinic visit.

Other: The Box 2.0

Controls

NO INTERVENTION

Patients will not receive a Box. They will be followed up by standard care, returning to the outpatient clinic at the same frequency and timing as The Box 2.0 arm.

Interventions

Patients in the intervention arm will receive a Box with several devices that is hypothesized to allow for better and earlier detection of complications after cardiac surgery.

The Box 2.0

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient undergoes cardiovascular surgery: CABG, valve reconstruction or replacement, aortic root or ascending aortic surgery, or any other cardiothoracic surgery performed by median sternotomy such as atrial or ventricular septal defect closure, Dor or Morrow procedure, cardiac tumor removal and/or surgical treatment of coronary artery anomalies.
  • Patient is able to communicate in English or Dutch
  • Patient has been referred by a cardiologist from the Leiden University Medical Center, Cardiological Center Voorschoten, Alrijne Hospital or Haaglanden Medical Center

You may not qualify if:

  • Patient is \< 18 years old
  • Patient is pregnant
  • Patient is considered an incapacitated adult
  • Patient is unwilling to sign the informed consent form
  • Patient undergoes emergency thoracic surgery (INTERMACS 1 or 2)
  • Patient has active endocarditis at the time of operation
  • Patient is on mechanical circulatory support before operation
  • Patient has a ventricular septal rupture
  • Patient undergoes extracorporeal membrane oxygenation or ventricular assist device insertion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leiden University Medical Centre

Leiden, South Holland, 2333 ZA, Netherlands

Location

Related Publications (1)

  • Biersteker TE, Boogers MJ, de Lind van Wijngaarden RA, Groenwold RH, Trines SA, van Alem AP, Kirchhof CJ, van Hof N, Klautz RJ, Schalij MJ, Treskes RW. Use of Smart Technology for the Early Diagnosis of Complications After Cardiac Surgery: The Box 2.0 Study Protocol. JMIR Res Protoc. 2020 Apr 21;9(4):e16326. doi: 10.2196/16326.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 24, 2018

First Posted

October 1, 2018

Study Start

October 2, 2018

Primary Completion

March 15, 2021

Study Completion

June 15, 2021

Last Updated

September 8, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations